Cargando…
MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
Objective: Tyrosine kinase inhibitors (TKIs) are used for the treatment of metastatic differentiated (DTC), poorly differentiated (PDTC) and medullary (MTC) thyroid cancer. Several adverse events (AEs) have been reported in almost all patients (pts) treated with TKIs. One of the less known AE relate...
Autores principales: | Valerio, Laura, Matrone, Antonio, Agate, Laura, Bottici, Valeria, Viola, David, Cappagli, Virginia, Giani, Carlotta, Molinaro, Eleonora, Elisei, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209016/ http://dx.doi.org/10.1210/jendso/bvaa046.1647 |
Ejemplares similares
-
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
por: Prete, Alessandro, et al.
Publicado: (2020) -
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020) -
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020) -
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center
por: Prete, Alessandro, et al.
Publicado: (2021) -
Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities
por: Lorusso, Loredana, et al.
Publicado: (2021)